Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
774
NCT05832931
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1
Phase: Phase 3
Role: Collaborator
Start: Apr 28, 2023
Completion: Jul 28, 2025
NCT05836220
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2
Start: May 15, 2023
Completion: Aug 5, 2025